High BAALC expression associates with other molecular prognostic markers, poor outcome and a distinct gene expression signature in cytogenetically normal acute myeloid leukemia (CN AML): A Cancer and Leukemia Group B (CALGB) study

被引：0
|
作者：
Langer, C.
Ruppert, A. S.
Radmacher, M. D.
Whitman, S. P.
Paschka, P.
Baldus, C. D.
Mrozek, K.
Kolitz, J. E.
Marcucci, G.
Bloomfield, C. D.
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Charite Campus Benjamin Franklin, Berlin, Germany
[3] North Shore Univ Hosp, Manhasset, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7013
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype:: a Cancer and Leukemia Group B study
    Radmacher, Michael D.
    Marcucci, Guido
    Ruppert, Amy S.
    Mrozek, Krzysztof
    Whitman, Susan P.
    Vardiman, James W.
    Paschka, Peter
    Vukosavljevic, Tamara
    Baldus, Claudia D.
    Kolitz, Jonathan E.
    Caligiuri, Michael A.
    Larson, Richard A.
    Bloomfield, Clara D.
    BLOOD, 2006, 108 (05) : 1677 - 1683
  • [22] Overexpression of the ERG gene is an adverse prognostic factor in acute myeloid leukemia (AML) with normal cytogenetics (NC):: A cancer and leukemia group B study (CALGB).
    Marcucci, G
    Baldus, CD
    Ruppert, AS
    Radmacher, MD
    Mrózek, K
    Whitman, SP
    Kolitz, JE
    Edwards, CG
    Vardiman, J
    Powell, BL
    Baer, MR
    Moore, JO
    Perrotti, D
    Caligiuri, MA
    Carroll, AJ
    Larson, RA
    de la Chapelle, A
    Bloomfield, CD
    BLOOD, 2005, 106 (11) : 101A - 101A
  • [23] BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics:: a Cancer and Leukemia Group B Study
    Baldus, CD
    Tanner, SM
    Ruppert, AS
    Whitman, SP
    Archer, KJ
    Marcucci, G
    Caligiuri, MA
    Carroll, AJ
    Vardiman, JW
    Powell, BL
    Allen, SL
    Moore, JO
    Larson, RA
    Kolitz, JE
    de la Chapelle, A
    Bloomfield, CD
    BLOOD, 2003, 102 (05) : 1613 - 1618
  • [24] Prognostic Significance of, and Gene and MicroRNA Expression Signatures Associated With, CEBPA Mutations in Cytogenetically Normal Acute Myeloid Leukemia With High-Risk Molecular Features: A Cancer and Leukemia Group B Study
    Marcucci, Guido
    Maharry, Kati
    Radmacher, Michael D.
    Mrozek, Krzysztof
    Vukosavljevic, Tamara
    Paschka, Peter
    Whitman, Susan P.
    Langer, Christian
    Baldus, Claudia D.
    Liu, Chang-Gong
    Ruppert, Amy S.
    Powell, Bayard L.
    Carroll, Andrew J.
    Caligiuri, Michael A.
    Kolitz, Jonathan E.
    Larson, Richard A.
    Bloomfield, Clara D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (31) : 5078 - 5087
  • [25] Prognostic Significance of Expression of a Single MicroRNA, miR-181a, in Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
    Schwind, Sebastian
    Maharry, Kati
    Radmacher, Michael D.
    Mrozek, Krzysztof
    Holland, Kelsi B.
    Margeson, Dean
    Whitman, Susan P.
    Hickey, Christopher
    Becker, Heiko
    Metzeler, Klaus H.
    Paschka, Peter
    Baldus, Claudia D.
    Liu, Shujun
    Garzon, Ramiro
    Powell, Bayard L.
    Kolitz, Jonathan E.
    Carroll, Andrew J.
    Caligiuri, Michael A.
    Larson, Richard A.
    Marcucci, Guido
    Bloomfield, Clara D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (36) : 5257 - 5264
  • [26] Distinct Gene Expression Profiles and Mutations Associate with Outcome in Younger Adults with De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) (Alliance)
    Walker, Christopher J.
    Eisfeld, Ann-Kathrin
    Ozer, Hatice G.
    Kohlschmidt, Jessica
    Nicolet, Deedra
    Mrozek, Krzysztof
    Papaioannou, Dimitrios
    Genutis, Luke K.
    Powell, Bayard L.
    Uy, Geoffrey L.
    Kolitz, Jonathan E.
    Carroll, Andrew J.
    Stone, Richard
    Garzon, Ramiro
    Byrd, John C.
    de la Chapelle, Albert
    Bloomfield, Clara D.
    BLOOD, 2019, 134
  • [27] Differential expression of various miRNAs in pediatric cytogenetically normal acute myeloid leukemia (CN-AML)
    Gaur, V.
    Chaudhary, S.
    Tyagi, A.
    Bakhshi, S.
    Sharma, P.
    Kumar, S.
    ANNALS OF ONCOLOGY, 2019, 30
  • [28] HIGH EXPRESSION OF DNMT3B NEGATIVELY IMPACTS ON CLINICAL OUTCOME OF OLDER PATIENTS (PTS) WITH PRIMARY CYTOGENETICALLY NORMAL (CN) ACUTE MYELOID LEUKEMIA (AML) [CALGB 20202 (ALLIANCE)]
    Niederwieser, C.
    Kohlschmidt, J.
    Maharry, K.
    Mrozek, K.
    Metzeler, K.
    Volinia, S.
    Yan, P.
    Frankhouser, D.
    Whitman, S.
    Becker, H.
    Eisfeld, A.
    Schwind, S.
    Curfman, J.
    Wu, Y.
    Baer, M.
    Powell, B.
    Kolitz, J.
    Moore, J.
    Carter, T.
    Marcucci, G.
    Bloomfield, C.
    HAEMATOLOGICA, 2013, 98 : 484 - 484
  • [29] Prognostic Prediction of Cytogenetically Normal Acute Myeloid Leukemia Based on a Gene Expression Model
    Yang, Liu
    Zhang, Houyu
    Yang, Xue
    Lu, Ting
    Ma, Shihui
    Cheng, Hui
    Yen, Kuangyu
    Cheng, Tao
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [30] Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: A Cancer and Leukemia Group B study
    Paschka, Peter
    Marcucci, Guido
    Ruppert, Amy S.
    Whitman, Susan P.
    Mrozek, Krzysztof
    Maharry, Kati
    Langer, Christian
    Baldus, Claudia D.
    Zhao, Weiqiang
    Powell, Bayard L.
    Baer, Maria R.
    Carroll, Andrew J.
    Caligiuri, Michael A.
    Kolitz, Jonathan E.
    Larson, Richard A.
    Bloomfield, Clara D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (28) : 4595 - 4602
12345